Survival of AAA patients following EVAR may be influenced by age, some inflammatory biomarkers such as white blood cell (WBC) and C-reactive protein (CRP), and comorbidities like diabetes, renal insufficiency and stroke (7, 8). Here, CRP is linked to triple-A syndrome.